Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 6/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27490698 | 0.92 | TSHR (0.56) | ATMALDH1A1TSHRRAB9ANPSR1 | |
| SCHEMBL3357403 | 0.87 | HCAR2 (0.42) | ATMALDH1A1TSHRHPGDRAB9A | |
| SCHEMBL8191642 | 0.86 | ATM (0.50) | ATMALDH1A1TSHRHPGDRAB9A | |
| SCHEMBL15641312 | 0.86 | ATM (0.50) | ATMALDH1A1TSHRHPGDRAB9A | |
| Hydrochloric Acid SCHEMBL5487401 | 0.84 | ATM (0.48) | ATMALDH1A1TSHRHPGDRAB9A | |
| SCHEMBL3355790 | 0.84 | ATM (0.48) | ATMALDH1A1TSHRHPGDRAB9A | |
| SCHEMBL9817168 | 0.82 | ATM (0.57) | ATMALDH1A1TSHRHPGDRAB9A | |
| SCHEMBL9817165 | 0.82 | ATM (0.57) | ATMALDH1A1TSHRHPGDRAB9A | |
| SCHEMBL9846747 | 0.82 | ATM (0.57) | ATMALDH1A1TSHRHPGDRAB9A | |
| SCHEMBL165647 | 0.80 | ALDH1A1 (0.56) | ATMALDH1A1TSHRHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2702035-B1 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | COUNCIL SCIENT IND RES (IN) | 2018-03-07 | — | — | EP | claimed |
| US-9199913-B2 | Process for continous flow synthesis of beta-amino crotonate | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | claimed |
| EP-2702035-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | Council of Scientific & Industrial Research (IN) | 2014-03-05 | — | — | EP | claimed |
| US-20140046090-A1 | PROCESS FOR CONTINOUS FLOW SYNTHESIS OF beta-AMINO CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-02-13 | — | — | US | claimed |
| WO-2012147103-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF β-ΑΜΙΝΟ CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-11-01 | — | — | WO | claimed |
| EP-4213980-A1 | AMINE MODIFIED POLYSACCHARIDE URETHANE/UREA MICROCAPSULES | Encapsys, LLC (US) | 2023-07-26 | — | — | EP | disclosed |
| WO-2022061103-A1 | AMINE MODIFIED POLYSACCHARIDE URETHANE/UREA MICROCAPSULES | ENCAPSYS, LLC (US) | 2022-03-24 | — | — | WO | disclosed |
| EP-2702035-B1 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | COUNCIL SCIENT IND RES (IN) | 2018-03-07 | — | — | EP | disclosed |
| US-9199913-B2 | Process for continous flow synthesis of beta-amino crotonate | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | disclosed |
| US-8993112-B2 | Polymeric particles | BASF SE (DE) | 2015-03-31 | — | — | US | disclosed |
| EP-2702035-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | Council of Scientific & Industrial Research (IN) | 2014-03-05 | — | — | EP | disclosed |
| US-20140046090-A1 | PROCESS FOR CONTINOUS FLOW SYNTHESIS OF beta-AMINO CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-02-13 | — | — | US | disclosed |
| WO-2012147103-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF β-ΑΜΙΝΟ CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-11-01 | — | — | WO | disclosed |
| EP-1756184-B1 | POLYMERIC PARTICLES | BASF SE (DE) | 2010-01-13 | — | — | EP | disclosed |
| US-20070255008-A1 | Polymeric Particles | CIBA CORPORATION | 2007-11-01 | — | — | US | disclosed |
| EP-1756184-A1 | POLYMERIC PARTICLES | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005123796-A1 | POLYMERIC PARTICLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140046090-A1 | PROCESS FOR CONTINOUS FLOW SYNTHESIS OF beta-AMINO CROTONATE | CACNA1C, CACNB3, CROCC | ATM 4369/4885ALDH1A1 1588/4885TSHR 4880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.